Literature DB >> 23820649

Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

David N Cooper1, Michael Krawczak, Constantin Polychronakos, Chris Tyler-Smith, Hildegard Kehrer-Sawatzki.   

Abstract

Some individuals with a particular disease-causing mutation or genotype fail to express most if not all features of the disease in question, a phenomenon that is known as 'reduced (or incomplete) penetrance'. Reduced penetrance is not uncommon; indeed, there are many known examples of 'disease-causing mutations' that fail to cause disease in at least a proportion of the individuals who carry them. Reduced penetrance may therefore explain not only why genetic diseases are occasionally transmitted through unaffected parents, but also why healthy individuals can harbour quite large numbers of potentially disadvantageous variants in their genomes without suffering any obvious ill effects. Reduced penetrance can be a function of the specific mutation(s) involved or of allele dosage. It may also result from differential allelic expression, copy number variation or the modulating influence of additional genetic variants in cis or in trans. The penetrance of some pathogenic genotypes is known to be age- and/or sex-dependent. Variable penetrance may also reflect the action of unlinked modifier genes, epigenetic changes or environmental factors. At least in some cases, complete penetrance appears to require the presence of one or more genetic variants at other loci. In this review, we summarize the evidence for reduced penetrance being a widespread phenomenon in human genetics and explore some of the molecular mechanisms that may help to explain this enigmatic characteristic of human inherited disease.

Entities:  

Mesh:

Year:  2013        PMID: 23820649      PMCID: PMC3778950          DOI: 10.1007/s00439-013-1331-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  699 in total

1.  Double heterozygosity in the BRCA1 and BRCA2 genes in the Jewish population.

Authors:  O Lavie; S Narod; F Lejbkowicz; S Dishon; Y Goldberg; O Gemer; G Rennert
Journal:  Ann Oncol       Date:  2010-10-05       Impact factor: 32.976

Review 2.  Beyond Mendel: an evolving view of human genetic disease transmission.

Authors:  Jose L Badano; Nicholas Katsanis
Journal:  Nat Rev Genet       Date:  2002-10       Impact factor: 53.242

3.  Digenic mutations in severe congenital neutropenia.

Authors:  Manuela Germeshausen; Cornelia Zeidler; Manfred Stuhrmann; Marina Lanciotti; Matthias Ballmaier; Karl Welte
Journal:  Haematologica       Date:  2010-03-10       Impact factor: 9.941

4.  Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.

Authors:  Sara L Van Driest; Vlad C Vasile; Steve R Ommen; Melissa L Will; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Journal:  J Am Coll Cardiol       Date:  2004-11-02       Impact factor: 24.094

5.  Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.

Authors:  B P Koeleman; P H Reitsma; C F Allaart; R M Bertina
Journal:  Blood       Date:  1994-08-15       Impact factor: 22.113

6.  Soluble epoxide hydrolase variant (Glu287Arg) modifies plasma total cholesterol and triglyceride phenotype in familial hypercholesterolemia: intrafamilial association study in an eight-generation hyperlipidemic kindred.

Authors:  Keiko Sato; Mitsuru Emi; Yoichi Ezura; Yuko Fujita; Daisuke Takada; Tomoaki Ishigami; Satoshi Umemura; Yunpei Xin; Lily L Wu; Stacey Larrinaga-Shum; Susan H Stephenson; Steven C Hunt; Paul N Hopkins
Journal:  J Hum Genet       Date:  2003-12-13       Impact factor: 3.172

7.  Copy number variations of the F8 gene are associated with venous thromboembolism.

Authors:  Wei Shen; Yi Gu; Rui Zhu; Lan Zhang; Jiwei Zhang; Chunmei Ying
Journal:  Blood Cells Mol Dis       Date:  2013-02-09       Impact factor: 3.039

8.  Analysis of the three most common MEFV mutations in 412 patients with familial Mediterranean fever.

Authors:  Nurit Zaks; Yael Shinar; Shai Padeh; Merav Lidar; Adam Mor; Irena Tokov; Mordechai Pras; Pnina Langevitz; Elon Pras; Avi Livneh
Journal:  Isr Med Assoc J       Date:  2003-08       Impact factor: 0.892

9.  A coding variant in CR1 interacts with APOE-ε4 to influence cognitive decline.

Authors:  Brendan T Keenan; Joshua M Shulman; Lori B Chibnik; Towfique Raj; Dong Tran; Mert R Sabuncu; April N Allen; Jason J Corneveaux; John A Hardy; Matthew J Huentelman; Cynthia A Lemere; Amanda J Myers; Anne Nicholson-Weller; Eric M Reiman; Denis A Evans; David A Bennett; Philip L De Jager
Journal:  Hum Mol Genet       Date:  2012-02-17       Impact factor: 6.150

10.  Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers.

Authors:  Logan C Walker; Zachary S Fredericksen; Xianshu Wang; Robert Tarrell; Vernon S Pankratz; Noralane M Lindor; Jonathan Beesley; Sue Healey; Xiaoqing Chen; Dominique Stoppa-Lyonnet; Carole Tirapo; Sophie Giraud; Sylvie Mazoyer; Danièle Muller; Jean-Pierre Fricker; Capucine Delnatte; Rita K Schmutzler; Barbara Wappenschmidt; Christoph Engel; Ines Schönbuchner; Helmut Deissler; Alfons Meindl; Frans B Hogervorst; Martijn Verheus; Maartje J Hooning; Ans Mw van den Ouweland; Marcel R Nelen; Margreet Gem Ausems; Cora M Aalfs; Christi J van Asperen; Peter Devilee; Monique M Gerrits; Quinten Waisfisz; Csilla I Szabo; Douglas F Easton; Susan Peock; Margaret Cook; Clare T Oliver; Debra Frost; Patricia Harrington; D Gareth Evans; Fiona Lalloo; Ros Eeles; Louise Izatt; Carol Chu; Rosemarie Davidson; Diana Eccles; Kai-Ren Ong; Jackie Cook; Tim Rebbeck; Katherine L Nathanson; Susan M Domchek; Christian F Singer; Daphne Gschwantler-Kaulich; Anne-Catharina Dressler; Georg Pfeiler; Andrew K Godwin; Tuomas Heikkinen; Heli Nevanlinna; Bjarni A Agnarsson; Maria Adelaide Caligo; Håkan Olsson; Ulf Kristoffersson; Annelie Liljegren; Brita Arver; Per Karlsson; Beatrice Melin; Olga M Sinilnikova; Lesley McGuffog; Antonis C Antoniou; Georgia Chenevix-Trench; Amanda B Spurdle; Fergus J Couch
Journal:  Breast Cancer Res       Date:  2010-11-29       Impact factor: 6.466

View more
  237 in total

Review 1.  Random monoallelic expression of autosomal genes: stochastic transcription and allele-level regulation.

Authors:  Björn Reinius; Rickard Sandberg
Journal:  Nat Rev Genet       Date:  2015-10-07       Impact factor: 53.242

2.  Plasma metabolomic profiles enhance precision medicine for volunteers of normal health.

Authors:  Lining Guo; Michael V Milburn; John A Ryals; Shaun C Lonergan; Matthew W Mitchell; Jacob E Wulff; Danny C Alexander; Anne M Evans; Brandi Bridgewater; Luke Miller; Manuel L Gonzalez-Garay; C Thomas Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

Review 3.  Genomics of Immune Diseases and New Therapies.

Authors:  Michael Lenardo; Bernice Lo; Carrie L Lucas
Journal:  Annu Rev Immunol       Date:  2015-12-23       Impact factor: 28.527

4.  The Hidden Complexity of Mendelian Traits across Natural Yeast Populations.

Authors:  Jing Hou; Anastasie Sigwalt; Téo Fournier; David Pflieger; Jackson Peter; Jacky de Montigny; Maitreya J Dunham; Joseph Schacherer
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

5.  A genome-wide case-only test for the detection of digenic inheritance in human exomes.

Authors:  Gaspard Kerner; Matthieu Bouaziz; Aurélie Cobat; Benedetta Bigio; Andrew T Timberlake; Jacinta Bustamante; Richard P Lifton; Jean-Laurent Casanova; Laurent Abel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

Review 6.  Applications of high-throughput DNA sequencing to benign hematology.

Authors:  Vijay G Sankaran; Patrick G Gallagher
Journal:  Blood       Date:  2013-09-10       Impact factor: 22.113

Review 7.  Emerging Role of Precision Medicine in Cardiovascular Disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Circ Res       Date:  2018-04-27       Impact factor: 17.367

8.  Unilateral retinitis pigmentosa occurring in an individual with a mutation in the CLRN1 gene.

Authors:  Peng Yong Sim; V Swetha E Jeganathan; Alan F Wright; Peter Cackett
Journal:  BMJ Case Rep       Date:  2018-03-15

9.  Missense variants in CFTR nucleotide-binding domains predict quantitative phenotypes associated with cystic fibrosis disease severity.

Authors:  David L Masica; Patrick R Sosnay; Karen S Raraigh; Garry R Cutting; Rachel Karchin
Journal:  Hum Mol Genet       Date:  2014-12-08       Impact factor: 6.150

Review 10.  Genetic Network Complexity Shapes Background-Dependent Phenotypic Expression.

Authors:  Jing Hou; Jolanda van Leeuwen; Brenda J Andrews; Charles Boone
Journal:  Trends Genet       Date:  2018-06-11       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.